An informational 2026 consumer report examining Purisaki Berberine Patches' transdermal delivery claims, ingredient research ...

An increasing number of women who use estrogen patches to help deal with perimenopause and menopause symptoms have been scrambling to access their transdermal drug amid a nationwide shortage of the ...

Estrogen patches, one of the most common forms of hormone therapy for women, are becoming harder to find, and some ...

There are other options for hormone therapy.

Rising interest in hormone therapy for premenopause and menopause symptoms has led to estrogen patch shortages. Experts share strategies to try to find this medication or stretch out what you have.

An estrogen patch shortage in the U.S. is disrupting menopause care, but doctors stress that there are other options for ...

For many women in the United States who encounter drenching night sweats, sudden hot flashes, debilitating exhaustion and other menopausal symptoms, small estradiol patches worn on the skin have ...

Key opportunities in the drug delivery devices market include expanding digital health partnerships for innovative injectable ...

With the removal of FDA warning labels, hormone therapy to treat symptoms of menopause has grown in popularity. Now some patients are reporting delays in filling prescriptions for estrogen patches.

ORLANDO, Fla., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW) today announced that it has signed an exclusive distribution agreement with Costa Rica Based Innomedica ...

The "Electronic Drug Delivery System Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. The electronic drug delivery system market expanded from USD 14.03 ...

Executive SummaryThe global pharmaceutical drug delivery sector operates as a central pillar within the broader life sciences industry. As treatment protocols shift from conventional dosing toward ...